Leveraging modular gene editors and new regulatory pathways, Aurora will develop and commercialize therapies that can be rapidly tailored to many rare variants -- Founded by CRISPR pioneers Jennifer ...
The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...
Abstract: In this technical note, we propose a model predictive control (MPC) framework for switched piecewise-affine (PWA) systems under dwell-time (DT) constraints, with guaranteed recursive ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, ...
Recursion Pharmaceuticals Inc has faced significant challenges in its financial performance, highlighted by a sharp decline in revenue growth, which fell to -32.98% in Q3 2025 from +30.14% in Q2 2025.
On a Tuesday at the end of last semester, I asked my first-year writing class how they were using AI in their courses. One of ...
Get the latest news and real-time alerts from Recursion Pharmaceuticals, Inc. (RXRX) stock at Seeking Alpha.
Condé Nast Traveler on MSN
The best city in the US for shopping is exactly the one you think it is
Condé Nast Traveler readers believe this major US city is the end-all-be-all for shopping destinations in the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback